CMMB vs ENLV: Side-by-Side Comparison
Compare Chemomab Therapeutics Ltd (CMMB) and Enlivex Therapeutics Ltd (ENLV) side by side: market cap USD 16.34M vs USD 126.26M. Financials, growth and model signals on Bullrun.
| Metric | CMMB | ENLV |
|---|---|---|
| Company | Chemomab Therapeutics Ltd | Enlivex Therapeutics Ltd |
| Country / Exchange | Israel · NASDAQ | Israel · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 16.34M | USD 126.26M |
| P/E ratio | — | 0.0 |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (FY2025) | — | — |
| Revenue growth YoY | — | — |
| Net income | USD -9.00M | USD 1.24B |
| Gross margin | — | — |
| Diluted EPS | 0.02 | 25.48 |